Left Atrial Appendage Occlusion
Conditions
Brief summary
A total of 60 patients with atrial fibrillation were scheduled to receive left atrial appendage occlusion, which were divided into two groups. The operation was performed under the guidance of intracardiac echocardiography and left atrial appendage radiography, respectively (allocation ratio 1:1). During the operation, the total amount of contrast medium injected, the fluoroscopy time and the time from femoral vein puncture to transseptal puncture to closure were recorded in all patients. The diameter and depth of the left atrial appendage opening were measured by angiography in group A(ICE group), and measured by ICE in group B(radiography group). The size of the occluder device was selected according to the measurement size of the two groups, the occluder device success rate of the two groups was compared, and the relationship between measurement size and the size of the occluder device was obtained.
Interventions
30 patients use intracardiac echocardiography to guide left atrial appendage occluder device, 30 patients use radiography to guide left atrial appendage occluder device.
Sponsors
Study design
Intervention model description
A total of 60 patients with atrial fibrillation were scheduled to receive left atrial appendage occlusion, which were divided into two groups. The operation was performed under the guidance of intracardiac echocardiography and left atrial appendage radiography, respectively (allocation ratio 1:1).
Eligibility
Inclusion criteria
patients taking class I and class III antiarrhythmic drugs could not prevent atrial fibrillation, patients younger than 80 years old Cha2ds2-vasc score ≥2 and Has-bled score ≥3, not suitable for long-term oral anticoagulant drugs.
Exclusion criteria
Patients with a history of atrial thrombosis or valvular heart disease (moderate or severe valve stenosis or severe valve regurgitation), patients undergoing prosthetic heart valve replacement, pregnant women, patients with previous liver and kidney diseases, malignant tumors or blood system diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| record contrast media as well as fluoroscopy time were recorded | in the procedure | record contrast media as well as fluoroscopy time were recorded in all patients |
| measure left atrial appendage opening and depth in different angles by intracardiac echocardiography | in the procedure | use intracardiac echocardiography to measure left atrial appendage opening and depth |
| measure left atrial appendage opening and depth in different angles by radiography | in the procedure | use left atrial appendage radiography to measure left atrial appendage opening and depth |
Countries
China